CAR T Cells to Target GD2 for DMG
NCT05544526
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Midline Glioma, H3 K27M-Mutant
Interventions
BIOLOGICAL:
GD2 CAR T cells
Sponsor
University College, London